Thursday, September 10, 2020
James R. Baldwin has joined McDonald Hopkins LLC in the Intellectual Property Department of the firm’s Chicago office.
Monday, June 29, 2020
Brian G. Bembenick has joined McDonald Hopkins LLC as Of Counsel in the firm’s Cleveland office, where he will bring 30 years of experience to the firm’s Intellectual Property Department.
Wednesday, June 10, 2020
James P. Muraff has joined the McDonald Hopkins LLC as a member in the firm’s Chicago office, where he will bring more than 25 years of experience to the firm’s Intellectual Property Department.
Wednesday, June 3, 2020
Four intellectual property considerations to keep in mind when adapting your business and products in these changing times to help mitigate risk of dispute, and also protect the your valuable brand and business assets for the future.
Friday, May 8, 2020
The U.S. Patent and Trademark Office announced a new Prioritized Examination Pilot Program for qualifying applications and applicants.
Tuesday, April 14, 2020
With numerous private entities, major national health centers, and non-governmental organizations concentrating their efforts on developing and bringing to market diagnostics, treatments and preventatives to combat COVID-19, the issue of patent protection—and potential enforcement of patents—has also come to the forefront.
Wednesday, April 1, 2020
On March 31, the United States Patent and Trademark Office announced extensions of certain patent and trademark deadlines under the recently passed CARES Act. The extensions provide relief for inventors and entrepreneurs during the COVID-19 crisis.
Thursday, March 26, 2020
Necessity breeds innovation. While faced with a worldwide shortage of medical equipment and personal protective equipment (PPE), many business owners are implementing drastic changes to their operations to step up and help fill the gaps.
Thursday, March 19, 2020
A summary of patent and trademark offices around the world that are granting automatic extensions or relaxing revival rules due to the coronavirus.
State and federal offices seek to protect consumers by cracking down on false and misleading COVID-19 treatment claims
Thursday, March 19, 2020
Earlier this month the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) jointly issued warning letters to seven companies—Vital Silver, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, and The Jim Bakker Show—for selling products that fraudulently claim to prevent, treat or cure COVID-19. The products cited in these warning letters are teas, essential oils, tinctures and colloidal silver, all of which FDA considers unapproved drugs that pose significant risks to patient health and violate federal law.